Advertisement

Oxytocin Injection

[01 December 2014]

Products Affected - Description

Oxytocin 10 unit/mL, Fresenius Kabi, USA
1 mL vial, 25 count (NDC 63323-0012-01)
10 mL vial, 25 count (NDC 63323-0012-10)
 
Oxytocin 10 unit/mL, West-Ward
1 mL vial, 25 count (NDC 00641-6114-25)
10 mL vial, 25 count (NDC 00641-6115-25)

Pitocin 10 unit/mL, Par Sterile Products (formerly JHP)
1 mL vial, 25 count (NDC 42023-0116-25)
10 mL vial, 1 count (NDC 42023-0116-01)
10 mL vial, 25 count (NDC 42023-0116-02)
50 mL bulk vial, 1 count (NDC 42023-0130-06)

Reason for the Shortage

  • Fresenius Kabi, USA (formerly APP) states the shortage is due to increased demand.
  • Par Sterile Products (formerly JHP) discontinued generic oxytocin injection in July 2014.
  • West-Ward states the shortage is due to stock becoming short-dated.
     

Available Products

Oxytocin 10 unit/mL, Fresenius Kabi, USA
30 mL vial, 10 count (NDC 63323-0012-30)

Estimated Resupply Dates

  • Fresenius has oxytocin 10 units/mL 1 mL vials on back order and the company estimates a release date in early-to-mid December 2014. Oxytocin 10 mL vials are available with short expiration dating (< 3 months dating).
  • West-Ward has oxytocin 10 units/mL 10 mL vials on back order and the company cannot estimate a release date. Oxytocin 10 units/mL 1 mL vials are available on allocation with short-expiration dating (January 2015).
  • Par Sterile Products has available in limited supply Pitocin 1 mL, 10 mL, and 50 mL vials.

Related Shortages

Updated

December 1, 2014; October 20, 2014; September 18, 2014; September 9, 2014; August 6, 2014; July 18, 2014; June 12, 2014; May 27, 2014; May 5, 2014; April 3, 2014; March 27, 2014; March 6, 2014; February 6, 2014; January 24, 2014; December 18, 2013; December 4, 2013; November 27, 2013; November 14, 2013; October 30, 2013; October 15, 2013; August 13, 2013; July 23, 2013; July 2, 2013; June 19, 2013; April 26, 2013; March 29, 2013; March 15, 2013; February 27, 2013; January 30, 2013; January 16, 2013; December 14, 2012; November 16, 2012; September 24, 2012; August 23, 2012; August 10, 2012; June 15, 2012; May 17, 2012; May 7, 2012; April 27, 2012; April 10, 2012; March 23, 2012; March 9, 2012; February 23, 2012; February 10, 2012; December 22, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement